Kelonia Therapeutics

Kelonia Therapeutics is pioneering new genetic medicines using its next-generation gene delivery platform. The company’s simple yet elegant cutting-edge in vivo gene delivery technology employs highly efficient lentivirus vector-like particles to precisely and effectively deliver genetic payloads to the desired target tissue each time, and exclusively to that tissue. Initially focused on developing transformative therapies for solid tumors and hematologic cancers, Kelonia Therapeutics is building a pipeline of genetic medicines for various diseases, with the bold goal of making gene therapy accessible to every patient in need.